Great Point Partners LLC

Great Point Partners LLC discloses dealings in 6 companies, chiefly AMAG Pharmaceuticals Inc., Memory Pharmaceuticals Corp and MEDecision, Inc. Between 21 February 2006 and 21 June 2017, the trades on record add up to 306 filings.

The open-market side counts 5 purchases for €1.7M alongside 289 sales for €38.9M. The net balance comes to €37.2M on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 6 share grants. So far in 2017, the count stands at no purchases and 3 sales.

In size, the median ticket on the buying side is €481k.

The latest filing, published on 21 June 2017, reports an open-market sale of €312k in Adamas Pharmaceuticals Inc. The last insider purchase was made public on 9 July 2008, 6,681 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.